Rules and Regulations. Notice
605 words·~3 min read·
/register/2023/03/07/2023-04628·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; NCI Genomic Data Commons
(GDC)Data Submission Request Form (National Cancer Institute) AGENCY: National Institutes of Health, HHS. ACTION: Notice. SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health
(NIH)has submitted to the Office of Management and Budget
(OMB)a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to *www.reginfo.gov/public/do/PRAMain.* Find this particular information collection by selecting “Currently under 30-day Review—Open for Public Comments” or using the search function. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Jean Claude Zenklusen, Ph.D., Scientific Program Director, Center for Cancer Genomics (CCG), National Cancer Institute, Building 31 Room 3A20, 31 Center Drive, Bethesda MD 20814 or call the non-toll-free number 301-781-3409 or Email your request, including your address to: *Jean.Zenklusen@nih.gov.* SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the **Federal Register** on November 7, 2022, page 67049 (Vol. 87 No. 215 FR 67049 and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health
(NIH)has submitted to the Office of Management and Budget
(OMB)a request for review and approval of the information collection listed below. *Proposed Collection:* NCI Genomic Data Commons
(GDC)Data Submission Request Form, 0925-0752, Expiration Date 3/31/2023, EXTENSION, National Cancer Institute (NCI), National Institutes of Health (NIH). *Need and Use of Information Collection:* The purpose of the NCI Genomic Data Commons
(GDC)Data Submission Request Form is to provide a vehicle for investigators to request the submission of their cancer genomic data into the GDC in support of data sharing. The purpose is also to provide a mechanism for the GDC Data Submission Review Committee to review and assess the data submission request for applicability to the GDC mission. The scope of the form involves obtaining information from investigators that:
(1)would like to submit data about their study into the GDC,
(2)are affiliated with studies that adhere to GDC data submission conditions. The benefits of the collection are that it provides the needed information for investigators to understand the types of studies and data that the GDC supports and allows for a standard mechanism for the GDC to assess incoming data submission requests. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 50 hours. Estimated Annualized Burden Hours Type of respondent Number of respondents Number of responses per respondent Average time per response (in hours) Total annual burden hour Investigator 200 1 15/60 50 Total 200 50 Dated: March 2, 2023. Diane Kreinbrink, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. [FR Doc. 2023-04628 Filed 3-6-23; 8:45 am]